Global Ropivacaine Market Status and Forecast 2021-2027

Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Ropivacaine Market Status and Forecast (2016-2027)
  • 1.3.2 Global Ropivacaine Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Ropivacaine Supply by Company

• 2.1 Global Ropivacaine Sales Volume by Company
• 2.2 Global Ropivacaine Sales Value by Company
• 2.3 Global Ropivacaine Price by Company
• 2.4 Ropivacaine Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Ropivacaine Market Status by Type

• 3.1 Ropivacaine Type Introduction
  • 3.1.1 Lumbar Epidural Administration
  • 3.1.2 Thoracic Epidural Administration
  • 3.1.3 Regional Block
• 3.2 Global Ropivacaine Market by Type
  • 3.2.1 Global Ropivacaine Sales Volume by Type (2016-2021)
  • 3.2.2 Global Ropivacaine Sales Value by Type (2016-2021)
  • 3.2.3 Global Ropivacaine Price by Type (2016-2021)
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Ropivacaine Market Status by Application

• 4.1 Ropivacaine Segment by Application
  • 4.1.1 Anesthesia
  • 4.1.2 Systemic Neuropathic Pain
  • 4.1.3 Postherpes Pain
  • 4.1.4 Post-Operative Pain
  • 4.1.5 Surgical Analgesia
  • 4.1.6 Labor Analgesia
  • 4.1.7 Other
• 4.2 Global Ropivacaine Market by Application
  • 4.2.1 Global Ropivacaine Sales Volume by Application (2016-2021)
  • 4.2.2 Global Ropivacaine Sales Value by Application (2016-2021)
  • 4.2.3 Global Ropivacaine Price by Application (2016-2021)
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Ropivacaine Market Status by Region

• 5.1 Global Ropivacaine Market by Region
  • 5.1.1 Global Ropivacaine Sales Volume by Region
  • 5.1.2 Global Ropivacaine Sales Value by Region
• 5.2 North America Ropivacaine Market Status
• 5.3 Europe Ropivacaine Market Status
• 5.4 Asia Pacific Ropivacaine Market Status
• 5.5 Central & South America Ropivacaine Market Status
• 5.6 Middle East & Africa Ropivacaine Market Status

6 North America Ropivacaine Market Status

• 6.1 North America Ropivacaine Market by Country
  • 6.1.1 North America Ropivacaine Sales Volume by Country (2016-2021)
  • 6.1.2 North America Ropivacaine Sales Value by Country (2016-2021)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Ropivacaine Market Status

• 7.1 Europe Ropivacaine Market by Country
  • 7.1.1 Europe Ropivacaine Sales Volume by Country (2016-2021)
  • 7.1.2 Europe Ropivacaine Sales Value by Country (2016-2021)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Ropivacaine Market Status

• 8.1 Asia Pacific Ropivacaine Market by Country
  • 8.1.1 Asia Pacific Ropivacaine Sales Volume by Country (2016-2021)
  • 8.1.2 Asia Pacific Ropivacaine Sales Value by Country (2016-2021)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Ropivacaine Market Status

• 9.1 Central & South America Ropivacaine Market by Country
  • 9.1.1 Central & South America Ropivacaine Sales Volume by Country (2016-2021)
  • 9.1.2 Central & South America Ropivacaine Sales Value by Country (2016-2021)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Ropivacaine Market Status

• 10.1 Middle East & Africa Ropivacaine Market by Country
  • 10.1.1 Middle East & Africa Ropivacaine Sales Volume by Country (2016-2021)
  • 10.1.2 Middle East & Africa Ropivacaine Sales Value by Country (2016-2021)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Ropivacaine Manufacturing Cost Analysis
• 11.5 Ropivacaine Sales Channel and Distributors Analysis
  • 11.5.1 Ropivacaine Sales Channel
  • 11.5.2 Ropivacaine Distributors
• 11.6 Ropivacaine Downstream Major Buyers

12 Global Ropivacaine Market Forecast by Type and by Application

• 12.1 Global Ropivacaine Sales Volume and Sales Value Forecast (2022-2027)
• 12.2 Global Ropivacaine Forecast by Type
  • 12.2.1 Global Ropivacaine Sales Volume Forecast by Type
  • 12.2.2 Global Ropivacaine Sales Value Forecast by Type
  • 12.2.3 Global Ropivacaine Price Forecast by Type
• 12.3 Global Ropivacaine Forecast by Application
  • 12.3.1 Global Ropivacaine Sales Volume Forecast by Application
  • 12.3.2 Global Ropivacaine Sales Value Forecast by Application
  • 12.3.3 Global Ropivacaine Price Forecast by Application

13 Global Ropivacaine Market Forecast by Region/Country

• 13.1 Global Ropivacaine Market Forecast by Region (2022-2027)
  • 13.1.1 Global Ropivacaine Sales Volume Forecast by Region (2022-2027)
  • 13.1.2 Global Ropivacaine Sales Value Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Zhejiang Xianju Pharmaceutical
  • 14.1.1 Company Information
  • 14.1.2 Ropivacaine Product Introduction
  • 14.1.3 Zhejiang Xianju Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Yichang Renfu Pharmaceutical
  • 14.2.1 Company Information
  • 14.2.2 Ropivacaine Product Introduction
  • 14.2.3 Yichang Renfu Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Yangtze Pharmaceutical Group
  • 14.3.1 Company Information
  • 14.3.2 Ropivacaine Product Introduction
  • 14.3.3 Yangtze Pharmaceutical Group Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Xi'an Hanfeng Pharmaceutical
  • 14.4.1 Company Information
  • 14.4.2 Ropivacaine Product Introduction
  • 14.4.3 Xi'an Hanfeng Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Taiwan Liposome Company
  • 14.5.1 Company Information
  • 14.5.2 Ropivacaine Product Introduction
  • 14.5.3 Taiwan Liposome Company Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Shenyang Sansheng Pharmaceutical
  • 14.6.1 Company Information
  • 14.6.2 Ropivacaine Product Introduction
  • 14.6.3 Shenyang Sansheng Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Shanxi Pude Pharmaceutical
  • 14.7.1 Company Information
  • 14.7.2 Ropivacaine Product Introduction
  • 14.7.3 Shanxi Pude Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Shandong New Era Pharmaceutical
  • 14.8.1 Company Information
  • 14.8.2 Ropivacaine Product Introduction
  • 14.8.3 Shandong New Era Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Shaanxi Bosen Biopharmaceutical
  • 14.9.1 Company Information
  • 14.9.2 Ropivacaine Product Introduction
  • 14.9.3 Shaanxi Bosen Biopharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Qilu Pharmaceutical
  • 14.10.1 Company Information
  • 14.10.2 Ropivacaine Product Introduction
  • 14.10.3 Qilu Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 PainReform Ltd
• 14.12 Nuvo Pharmaceuticals
• 14.13 Jiangsu Hengrui Pharmaceutical
• 14.14 Jiangsu Enhua Pharmaceutical
• 14.15 Heron Therapeutics
• 14.16 Hebei Yipin Pharmaceutical
• 14.17 Hainan Sida Pharmaceutical
• 14.18 Guangdong Jiabo Pharmaceutical
• 14.19 Guangdong Huarun Shunfeng Pharmaceutical
• 14.20 Encore Therapeutics
• 14.21 Chenxin Pharmaceutical
• 14.22 Chengdu Tiantaishan Pharmaceutical
• 14.23 Celgene
• 14.24 AstraZeneca
• 14.25 Aspen Pharmacare
• 14.26 Anhui Wellman Pharmaceutical

15 Conclusion

16 Methodology